GSI 9883 Pill - brown capsule/oblong, 15mm
Generic Name: bictegravir/emtricitabine/tenofovir alafenamide
Pill with imprint GSI 9883 is Brown, Capsule/Oblong and has been identified as Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg. It is supplied by Gilead Sciences, Inc.
Biktarvy is used in the treatment of HIV Infection and belongs to the drug class antiviral combinations. Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 9883
Biktarvy
- Generic Name
- bictegravir/emtricitabine/tenofovir alafenamide
- Imprint
- GSI 9883
- Strength
- bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg
- Color
- Brown
- Size
- 15.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-2501
- Inactive Ingredients
-
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
water,
titanium dioxide,
magnesium silicate,
ferrosoferric oxide,
ferric oxide red
Note: Inactive ingredients may vary.
More about Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (200)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antiviral combinations
- En español
Patient resources
Professional resources
- Biktarvy prescribing information
- Bictegravir, Emtricitabine, and Tenofovir Alafenamide (AHFS Monograph)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
